Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)

Mark D Lyttle, Julia Bielicki, Sam Barratt, David Dunn, Adam Finn, Lynda Harper, Pauline Jackson, Colin VE Powell, Damian Roland, Wolfgang Stöhr, Kate Sturgeon, Mandy Wan, Paul Little, Saul N Faust, Julie Robotham, Alastair Hay, Diana M Gibb, Mike Sharland, On behalf of PERUKI, GAPRUKI and the CAP-IT trial team

Research output: Contribution to journal › Article (Academic Journal) › peer-review

10 Citations (Scopus)
322 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)'. Together they form a unique fingerprint.

Medicine & Life Sciences